CoChat

SaLT&PepPr is an interface-predicting language model for designing peptide-guided protein degraders

Open access
Brixi, Garyk, Ye, Tianzheng, Hong, Lauren, Wang, Tian, Monticello, Connor, Lopez-Barbosa, Natalia, Vincoff, Sophia, Yudistyra, Vivian, Zhao, Lin, Haarer, Elena, Chen, Tianlai, Pertsemlidis, Sarah, Palepu, Kalyan, Bhat, Suhaas, Christopher, Jayani, Li, Xinning, Liu, Tong, Zhang, Sue, Petersen, Lillian, DeLisa, Matthew P., Chatterjee, Pranam · 2023 · Communications Biology
Cited by 42

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Protein-protein interactions (PPIs) are critical for biological processes and predicting the sites of these interactions is useful for both computational and experimental applications. We present a S tructure-a gnostic L anguage T ransformer and Pep tide Pr ioritization (SaLT&PepPr) pipeline to predict interaction interfaces from a protein sequence alone for the subsequent generation of peptidic binding motifs. Our model fine-tunes the ESM-2 protein language model (pLM) with a per-position prediction task to identify PPI sites using data from the PDB, and prioritizes motifs which are most likely to be involved within inter-chain binding. By only using amino acid sequence as input, our model is competitive with structural homology-based methods, but exhibits reduced performance compared with deep learning models that input both structural and sequence features. Inspired by our previous results using co-crystals to engineer target-binding “guide” peptides, we curate PPI databases to identify partners for subsequent peptide derivation. Fusing guide peptides to an E3 ubiquitin ligase domain, we demonstrate degradation of endogenous β-catenin, 4E-BP2, and TRIM8, and highlight the nanomolar binding affinity, low off-targeting propensity, and function-altering capability of our best-performing degraders in cancer cells. In total, our study suggests that prioritizing binders from natural interactions via pLMs can enable programmable protein targeting and modulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-023-05464-z

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 21

  1. Portnoff, A. D., Stephens, E. A., Varner, J. D. & DeLisa, M. P. Ubiquibodies, synthetic E3 ubiquitin ligases endowed with unnatural substrate specificity for targeted protein silencing. J. Biol. Chem. 289, 7844–7855 (2014). · DOI · Paper page
  2. Chatterjee, P. et al. Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions. Commun. Biol. 3, 1–8 (2020). · DOI · Paper page
  3. Stephens, E. A. et al. Engineering single pan-specific ubiquibodies for targeted degradation of all forms of endogenous ERK protein kinase. ACS Synth. Biol. 10, 2396–2408 (2021). · DOI · Paper page
  4. Wang, J. Y. & Doudna, J. A. CRISPR technology: a decade of genome editing is only the beginning. Science 379, eadd8643 (2023). · DOI · Paper page
  5. Oughtred, R. et al. The BioGRID interaction database: 2019 update. Nucleic Acids Res. 47, D529–D541 (2019). · DOI · Paper page
  6. Johnson, K. L. et al. Revealing protein-protein interactions at the transcriptome scale by sequencing. Mol. Cell 81, 4091–4103.e9 (2021). · DOI
  7. Porras, P. et al. Towards a unified open access dataset of molecular interactions. Nat. Commun. 11, 1–12 (2020). · DOI · Paper page
  8. Seong, B. K. A. et al. TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma. Cancer Cell 39, 1262–1278.e7 (2021). · DOI · Paper page
  9. Sedan, Y., Marcu, O., Lyskov, S. & Schueler-Furman, O. Peptiderive server: derive peptide inhibitors from protein-protein interactions. Nucleic Acids Res. 44, W536–41 (2016). · DOI · Paper page
  10. Hurwitz, N., Zaidman, D. & Wolfson, H. J. Pep-Whisperer: inhibitory peptide design. Proteins 90, 1886–1895 (2022). · DOI
  11. Palepu, K. et al. Design of Peptide-Based Protein Degraders via Contrastive Deep Learning. bioRxiv 2022.05.23.493169. https://doi.org/10.1101/2022.05.23.493169 (2022). · DOI · Paper page
  12. Bhat, S. et al. De Novo Generation and Prioritization of Target-Binding Peptide Motifs from Sequence Alone. bioRxiv 2023.06.26.546591. https://doi.org/10.1101/2023.06.26.546591 (2023). · DOI · Paper page
  13. Huber, A. H. & Weis, W. I. The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell 105, 391–402 (2001). · DOI · Paper page
  14. Korinek, V. et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275, 1784–1787 (1997). · DOI · Paper page
  15. Ludwicki, M. B. et al. Broad-spectrum proteome editing with an engineered bacterial ubiquitin ligase mimic. ACS Cent. Sci. 5, 852–866 (2019). · DOI · Paper page
  16. Ding, M. et al. The mTOR targets 4E-BP1/2 restrain tumor growth and promote hypoxia tolerance in PTEN-driven prostate cancer. Mol. Cancer Res. 16, 682–695 (2018). · DOI
  17. Petroulakis, E. et al. p53-dependent translational control of senescence and transformation via 4E-BPs. Cancer Cell 16, 439–446 (2009). · DOI
  18. Tsukiyama-Kohara, K. et al. Tissue distribution, genomic structure, and chromosome mapping of mouse and human eukaryotic initiation factor 4E-binding proteins 1 and 2. Genomics 38, 353–363 (1996). · DOI
  19. To, T.-L. et al. Rational design of a GFP-based fluorogenic caspase reporter for imaging apoptosis in vivo. Cell Chem. Biol. 23, 875–882 (2016). · DOI
  20. Kundrotas, P. J. et al. Dockground: a comprehensive data resource for modeling of protein complexes. Protein Sci. 27, 172–181 (2018). · DOI · Paper page
  21. Cong, F., Zhang, J., Pao, W., Zhou, P. & Varmus, H. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. BMC Mol. Biol. 4, 10 (2003). · DOI

Cited by

See all 42

Metadata

Authors
Brixi, G., Ye, T., Hong, L., Wang, T., Monticello, C., Lopez-Barbosa, N., Vincoff, S., Yudistyra, V., Zhao, L., Haarer, E., Chen, T., Pertsemlidis, S., Palepu, K., Bhat, S., Christopher, J., Li, X., Liu, T., Zhang, S., Petersen, L., DeLisa, M. P., & Chatterjee, P.
Venue
Communications Biology
Published
2023-10-24
Volume
6
Issue
1
Pages
1081-1081
ISSN
2399-3642 (ISSN-L)
OpenAlex
W4387906121
Cited by
42
References
8
FWCI
3.14
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SaLT&PepPr is an interface-predicting language model for designing peptide-guided protein degraders. https://app.cochat.ai/papers/10.1038/s42003-023-05464-z
The paper
Brixi, G., Ye, T., Hong, L., Wang, T., Monticello, C., Lopez-Barbosa, N., Vincoff, S., Yudistyra, V., Zhao, L., Haarer, E., Chen, T., Pertsemlidis, S., Palepu, K., Bhat, S., Christopher, J., Li, X., Liu, T., Zhang, S., Petersen, L., . . . Chatterjee, P. (2023). SaLT&PepPr is an interface-predicting language model for designing peptide-guided protein degraders. Communications Biology. https://doi.org/10.1038/s42003-023-05464-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.